APA Citation

Sharman, J., Hawkins, M., Kolibaba, K., Boxer, M., Klein, L., Wu, M., . . . Yasenchak, C. (2015). An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia. Blood.

Chicago Style Citation

Sharman, Jeff, Michael Hawkins, Kathryn Kolibaba, Michael Boxer, Leonard Klein, Meihua Wu, Jing Hu, Steve Abella, and Chris Yasenchak. "An Open-label Phase 2 Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Chronic Lymphocytic Leukemia." Blood 2015.

MLA Citation

Sharman, Jeff, et al. "An Open-label Phase 2 Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Chronic Lymphocytic Leukemia." Blood 2015.

Warning: These citations may not always be 100% accurate.